Patents by Inventor Peter JS CHIU

Peter JS CHIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MORPHINAN DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS
    Publication number: 20210130316
    Abstract: Novel antagonists of toll-like receptor 4 (TLR-4) are provided. More specifically, the novel antagonists of TLR-4 are derived from morphinan. Further, use of said morphinan derivatives in the treatment of diseases and/or disorders mediated by TLR-4, such as autoimmune diseases, inflammation disease and infectious diseases, is provided. Pharmaceutical compositions including said morphinan derivatives are also provided.
    Type: Application
    Filed: December 19, 2017
    Publication date: May 6, 2021
    Applicant: TAIWANJ PHARMACEUTICALS CO., LTD
    Inventors: Syaulan S. YANG, Kuang-Yuan LEE, Edwin SC WU, Ming-Yu HSIAO, Hsiao-Chun WANG, Meng-Hsien LIU, Peter JS CHIU
  • SULFONAMIDE OR AMIDE COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND/OR TREATMENT OF AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS
    Publication number: 20200247761
    Abstract: The present invention related to novel sulfonamides or amides as TLR-4 antagonists, and pharmaceutical formulations containing the same and the methods of use thereof. Uses of the present novel sulfonamides or amides include, but are not limited to, the prophylaxis and/or treatment of autoimmune, inflammation, or infection related disorders.
    Type: Application
    Filed: January 25, 2018
    Publication date: August 6, 2020
    Applicant: TAIWANJ PHARMACEUTICALS CO., LTD
    Inventors: Syaulan S. YANG, Kuang-Yuan LEE, Meng-Hsien LIU, Ming-Yu HSIAO, Huang-Kai PENG, Chiung-Wen WANG, Edwin SC WU, Peter JS CHIU
  • TOLL-LIKE RECEPTOR 4 ANTAGONISTS AND USE IN AUTOIMMUNE LIVER DISEASES
    Publication number: 20160287578
    Abstract: The present invention relates to new medical uses of morphinans such as naltrexone, nalmefene and their related derivatives. The present invention relates to Toll-like receptor 4 (TLR4) antagonist compounds, and pharmaceutical formulations thereof, and use thereof for prevention and treatment of autoimmune liver diseases including but not limited to autoimmune hepatitis.
    Type: Application
    Filed: March 23, 2016
    Publication date: October 6, 2016
    Inventors: Peter JS CHIU, Mei-chi HSU, Ying-Chu SHIH, Edwin SC WU